Taigang Mo

Title: Taigang Mo: Innovator in Heavy Metal Chelating Agents

Introduction

Taigang Mo is a prominent inventor based in Sichuan, China. He has made significant contributions to the field of medicine and health protection through his innovative research. His work focuses on developing new heavy metal chelating agents that can be used for oral administration.

Latest Patents

Taigang Mo holds a patent for a heavy metal chelating agent for oral administration, its synthesis, and its uses in medicine and health protection. The patent describes a new kind of heavy metal chelating agents, specifically α-[D(+ )glucose-1-yl-amino]-β3-mercapto-(S)-propanoic acid (abbreviated to NGP,I) and/or N,N′-di[D(+ )glucose-1-yl]-L-cystine (abbreviated to NGCD,II). The preparation process involves reacting glucose and cysteine with a base and a reducing agent, followed by acidification to yield NGP,I. This compound is designed to accelerate the excretion of heavy metals such as Pb, Cd, Hg, Al, Sb, and As. The structural features of these compounds include glucose and cysteine, which contribute to their effectiveness. Compared to prior art heavy metal-excreting drugs, these compounds offer advantages such as suitability for oral administration, high excretion acceleration, selectivity, and reduced toxicity. Taigang Mo has 1 patent to his name.

Career Highlights

Taigang Mo is affiliated with the Sichuan Research Institute of Nature Drugs, where he conducts his research and development activities. His work has garnered attention for its potential applications in health and medicine.

Collaborations

Taigang Mo has collaborated with notable colleagues, including Shiqi Peng and Chao Wang, to advance his research in heavy metal chelation.

Conclusion

Taigang Mo's innovative work in developing heavy metal chelating agents represents a significant advancement in medical science. His contributions have the potential to improve health outcomes by providing effective solutions for heavy metal detoxification.